Skip to main navigation

Careers
Investors & Media
Contact

SCIENCE
PIPELINE
DISEASE FOCUS
HAE COMMUNITY
CLINICAL TRIALS
ABOUT US

Events

Investor Menu

IR Nav

Overview
News & Events
News Releases Events Publications
Financials
SEC Filings Quarterly Results
Stock
Stock Performance Analyst Coverage
Corporate Governance
Governance Documents Leadership Board of Directors Committee Composition
Resources
Investor FAQs Contact Us Email Alerts

Upcoming Events

Jun 26, 2026 10:00 AM EDT

2026 Annual General Meeting of Shareholders

Add to Google Calendar

Supporting Materials

2025 Annual Report 4 MB

Convening Notice and Agenda 259.8 KB

Voting Proxy 198.5 KB

Past Events

Jun 29, 2021 1:00 PM CEST

2021 Annual General Meeting of Shareholders

Supporting Materials

Annual Report and auditor's report 2020 1.9 MB

Convening Notice and Agenda (incl. explanatory notes) 185.3 KB

AGM Announcement 53.6 KB

Voting Proxy 154.9 KB

Jun 4, 2021 9:45 AM CEST

12th C1-Inhibitor Deficiency Angioedema Workshop

Supporting Materials

PHVS 2021 C1-INH Workshop Presentation 3.7 MB

Pharvaris Presents Pharmacokinetic and Pharmacodynamic Data for Oral PHA121, Under Development for the Treatment of HAE, at 12th C1 Inhibitor Deficiency and Angioedema Workshop

Feb 26 - Mar 1, 2021

2021 AAAAI Annual Meeting

Supporting Materials

Pharvaris to Present Clinical Data of PHA121 for the Treatment of Hereditary Angioedema at the 2021 AAAAI Annual Meeting

Pharvaris AAAAI 2021 Late Breaker Poster L23 1.4 MB

Pharvaris Presents Pharmacodynamic Activity of Oral PHA121, Under Development for the Treatment of HAE, at the AAAAI Annual Meeting

Pagination

First page
Previous page
…
Page 8
Page 9
Current page 10

Presentations

Latest Corporate Presentation

FOLLOW US

©2026 Pharvaris N.V. © All Rights Reserved

Privacy Policy
Clinical Trial Privacy Notice
Global Privacy Laws
Terms of Use